Christopher MacLeod

Christopher MacLeod

Director/Board Member at ZOMEDICA CORP.

Net worth: - $ as of 2024-04-29

54 year
Commercial Services
Consumer Services
Industrial Services

Profile

Christopher R.
MacLeod
is currently the Chairman of the Canadian Cystic Fibrosis Treatment Society, Pascal WealthTech, Inc., Patients Canada, and an Independent Director of Zomedica Corp.
He is also a Director of Pascal Financial.
Previously, he was a Partner at Cambridge LLP and held Director positions at Deploy Technologies, Inc. and Body & Mind, Inc. He received his undergraduate degree from the University of Regina in 1995 and his graduate degree from the University of Saskatchewan in 2000.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-16 0 ( -.--% ) - $ 2024-04-29

Christopher MacLeod active positions

CompaniesPositionStart
ZOMEDICA CORP. Director/Board Member 2020-07-08
Director/Board Member 2019-12-10
Corporate Officer/Principal 2009-12-31
Pascal Financial Director/Board Member -
Canadian Cystic Fibrosis Treatment Society Chairman -
Chairman 2019-01-31
All active positions of Christopher MacLeod

Former positions of Christopher MacLeod

CompaniesPositionEnd
BODY AND MIND INC. Director/Board Member 2018-11-04
Director/Board Member -
See the detail of Christopher MacLeod's experience

Training of Christopher MacLeod

University of Regina Undergraduate Degree
University of Saskatchewan Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher MacLeod's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ZOMEDICA CORP.

Health Technology

BODY AND MIND INC.

Process Industries

Private companies6

Industrial Services

Commercial Services

Commercial Services

Pascal Financial

Canadian Cystic Fibrosis Treatment Society

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher MacLeod